2018-2023 Global Dry Eye Disease Consumption Market Report
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Dry Eye Disease market for 2018-2023.
Dry eye disease is a multifactorial disease which is characterized by insufficiency of tears in eye. Insufficient lubrication in eye lead to burning, sensing, redness and pain in eye.
Over the next five years, LPI(LP Information) projects that Dry Eye Disease will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Eye Disease market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Artificial Tears
Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast)
Punctal Plugs
Secretagogue
Segmentation by application:
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Santen
Novartis
llergan
Shire
TRB Chemedica
Sun Pharmaceutical
Senju
Sentiss Pharma
Johnson & Johnson
Otsuka
Mitotech
FCI
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Dry Eye Disease consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Dry Eye Disease market by identifying its various subsegments.
Focuses on the key global Dry Eye Disease manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dry Eye Disease with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dry Eye Disease submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Dry Eye Disease Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dry Eye Disease Consumption 2013-2023
2.1.2 Dry Eye Disease Consumption CAGR by Region
2.2 Dry Eye Disease Segment by Type
2.2.1 Artificial Tears
2.2.2 Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast)
2.2.3 Punctal Plugs
2.2.4 Secretagogue
2.3 Dry Eye Disease Consumption by Type
2.3.1 Global Dry Eye Disease Consumption Market Share by Type (2013-2018)
2.3.2 Global Dry Eye Disease Revenue and Market Share by Type (2013-2018)
2.3.3 Global Dry Eye Disease Sale Price by Type (2013-2018)
2.4 Dry Eye Disease Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Independent Pharmacies & Drug Stores
2.4.3 Online pharmacies
2.5 Dry Eye Disease Consumption by Application
2.5.1 Global Dry Eye Disease Consumption Market Share by Application (2013-2018)
2.5.2 Global Dry Eye Disease Value and Market Share by Application (2013-2018)
2.5.3 Global Dry Eye Disease Sale Price by Application (2013-2018)
3 Global Dry Eye Disease by Players
3.1 Global Dry Eye Disease Sales Market Share by Players
3.1.1 Global Dry Eye Disease Sales by Players (2016-2018)
3.1.2 Global Dry Eye Disease Sales Market Share by Players (2016-2018)
3.2 Global Dry Eye Disease Revenue Market Share by Players
3.2.1 Global Dry Eye Disease Revenue by Players (2016-2018)
3.2.2 Global Dry Eye Disease Revenue Market Share by Players (2016-2018)
3.3 Global Dry Eye Disease Sale Price by Players
3.4 Global Dry Eye Disease Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Dry Eye Disease Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Dry Eye Disease Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dry Eye Disease by Regions
4.1 Dry Eye Disease by Regions
4.1.1 Global Dry Eye Disease Consumption by Regions
4.1.2 Global Dry Eye Disease Value by Regions
4.2 Americas Dry Eye Disease Consumption Growth
4.3 APAC Dry Eye Disease Consumption Growth
4.4 Europe Dry Eye Disease Consumption Growth
4.5 Middle East & Africa Dry Eye Disease Consumption Growth
5 Americas
5.1 Americas Dry Eye Disease Consumption by Countries
5.1.1 Americas Dry Eye Disease Consumption by Countries (2013-2018)
5.1.2 Americas Dry Eye Disease Value by Countries (2013-2018)
5.2 Americas Dry Eye Disease Consumption by Type
5.3 Americas Dry Eye Disease Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Dry Eye Disease Consumption by Countries
6.1.1 APAC Dry Eye Disease Consumption by Countries (2013-2018)
6.1.2 APAC Dry Eye Disease Value by Countries (2013-2018)
6.2 APAC Dry Eye Disease Consumption by Type
6.3 APAC Dry Eye Disease Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Dry Eye Disease by Countries
7.1.1 Europe Dry Eye Disease Consumption by Countries (2013-2018)
7.1.2 Europe Dry Eye Disease Value by Countries (2013-2018)
7.2 Europe Dry Eye Disease Consumption by Type
7.3 Europe Dry Eye Disease Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Dry Eye Disease by Countries
8.1.1 Middle East & Africa Dry Eye Disease Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Dry Eye Disease Value by Countries (2013-2018)
8.2 Middle East & Africa Dry Eye Disease Consumption by Type
8.3 Middle East & Africa Dry Eye Disease Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Dry Eye Disease Distributors
10.3 Dry Eye Disease Customer
11 Global Dry Eye Disease Market Forecast
11.1 Global Dry Eye Disease Consumption Forecast (2018-2023)
11.2 Global Dry Eye Disease Forecast by Regions
11.2.1 Global Dry Eye Disease Forecast by Regions (2018-2023)
11.2.2 Global Dry Eye Disease Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Dry Eye Disease Forecast by Type
11.8 Global Dry Eye Disease Forecast by Application
12 Key Players Analysis
12.1 Santen
12.1.1 Company Details
12.1.2 Dry Eye Disease Product Offered
12.1.3 Santen Dry Eye Disease Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Santen News
12.2 Novartis
12.2.1 Company Details
12.2.2 Dry Eye Disease Product Offered
12.2.3 Novartis Dry Eye Disease Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Novartis News
12.3 llergan
12.3.1 Company Details
12.3.2 Dry Eye Disease Product Offered
12.3.3 llergan Dry Eye Disease Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 llergan News
12.4 Shire
12.4.1 Company Details
12.4.2 Dry Eye Disease Product Offered
12.4.3 Shire Dry Eye Disease Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Shire News
12.5 TRB Chemedica
12.5.1 Company Details
12.5.2 Dry Eye Disease Product Offered
12.5.3 TRB Chemedica Dry Eye Disease Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 TRB Chemedica News
12.6 Sun Pharmaceutical
12.6.1 Company Details
12.6.2 Dry Eye Disease Product Offered
12.6.3 Sun Pharmaceutical Dry Eye Disease Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Sun Pharmaceutical News
12.7 Senju
12.7.1 Company Details
12.7.2 Dry Eye Disease Product Offered
12.7.3 Senju Dry Eye Disease Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Senju News
12.8 Sentiss Pharma
12.8.1 Company Details
12.8.2 Dry Eye Disease Product Offered
12.8.3 Sentiss Pharma Dry Eye Disease Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Sentiss Pharma News
12.9 Johnson & Johnson
12.9.1 Company Details
12.9.2 Dry Eye Disease Product Offered
12.9.3 Johnson & Johnson Dry Eye Disease Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Johnson & Johnson News
12.10 Otsuka
12.10.1 Company Details
12.10.2 Dry Eye Disease Product Offered
12.10.3 Otsuka Dry Eye Disease Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Otsuka News
12.11 Mitotech
12.12 FCI
13 Research Findings and Conclusion
